Defining T Cell States Associated with Response to Checkpoint Immunotherapy in MelanomaMoshe Sade-Feldman, Nir Hacohen, Keren Yizhak et al.|Cell|2018Cited by 2k
Resistance to checkpoint blockade therapy through inactivation of antigen presentationMoshe Sade-Feldman, Nir Hacohen, Dennie T. Frederick et al.|Nature Communications|2017Cited by 1k
<i>Ex Vivo</i> Profiling of PD-1 Blockade Using Organotypic Tumor SpheroidsRussell W. Jenkins, Mei-Ju Su, Amir Reza Aref et al.|Cancer Discovery|2017Cited by 591
Supp. Movie 3 from <i>Ex Vivo</i> Profiling of PD-1 Blockade Using Organotypic Tumor SpheroidsRussell W. Jenkins, Mei-Ju Su, Amir Reza Aref et al.|Unknown|2023Cited by 0
Table S4 from <i>Ex Vivo</i> Profiling of PD-1 Blockade Using Organotypic Tumor SpheroidsRussell W. Jenkins, Mei-Ju Su, Amir Reza Aref et al.|Unknown|2023Cited by 0